The completed and ongoing global trials with oral semaglutide includes more than 10,000 patients of which more than 1,000 participants are from India
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost ~28.7% of body weight (~71 lbs at 68 weeks) and saw substantial improvements in pain and function: WOMAC pain scores reduced by 4.5 points (75.8%) Meaningful gains in physical function, with many patients essentially free of knee pain by study end If these results are confirmed in broader use, were not just talking about weight loss drugs anymorewere talking about disease-modifying therapies that simultaneously target obesity, pain, mobility, and downstream CV risk
Completion of an online assessment does not establish a doctorpatient relationship, which is formed only after clinical review and acceptance by a licensed NexLife-affiliated provider
In this autoimmune condition, your body turns against its thyroid, hijacking energy and metabolism and causing fatigue, weight gain, and other debilitating symptoms